Page 339 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 339
P1273 ACUTE PORTALVEINTHROMBOSIS: CLINICAL FEATURES, ePOSTERS
P1274 DIAGNOSIS AND OUTCOMES AFTER 5YEARS OF FOLLOW-UP
P1275 Armando Peixoto*, Marco Silva, Pedro Pereira, Guilherme Macedo,
P1276 Portugal
P1277
P1278 SUPPORTIVE AND PALLIATIVE CARE IN ADVANCED LIVER
P1279 DISEASE: PATIENTS’ NEEDS AND PRIORITIES
P1280 Barbara M. Kimbell*, Marilyn Kendall, Kirsty Boyd, Scott A. Murray,
The United Kingdom
STIGMA AND DISCRIMINATION IN VIRAL HEPATITIS -
THE VOICE OF THE PATIENT
Carlos N. Varaldo*, Joana Costa, Ana R. Pascom, Vanuza M. Postigo,
Brazil
VITAMIN D SUPPLEMENTATION FOR CHRONIC LIVER
DISEASE - A COCHRANE HEPATO-BILIARY GROUP
SYSTEMATIC REVIEW
Goran Bjelakovic*, Dimitrinka Nikolova, Marija Bjelakovic,
Christian Gluud, Republic of Serbia
SCREENING FOR VIRAL HEPATITIS AMONG MIGRANTS
IN THE EU: WHAT LESSONS CAN WE LEARN FROM POOR
RESPONSE TO A PILOT TRIAL USING GP REGISTERS?
Jan Kunkel*, Lorna Sweeney, Abby Falla, Irene Veldhuijzen,
Graham R. Foster, The United Kingdom
EFFECTS OF “CHRONIC HEPATITIS PATIENTS
INFORMATION AND MORALE MEETINGS” ON PATIENT
COMPLIANCE AND TREATMENT SUCCESS
Orhan Sezgin*, Engin Altıntaş, Enver Üçbilek, Fehmi Ateş, Serkan Yaraş,
Bünyamin Sarıtaş, Mehmet K. Aydın, Turkey
MORTALITY, PREMATURE DEATH AND DIRECT COSTS
ASSOCIATED WITH LIVER DISEASE IN PORTUGAL
Sofia Vítor*, Rui T. Marinho, José Gíria, Portugal
THE DYNAMICS IN GENERAL AND LIVER DISEASE
SPECIFIC ASPECTS OF QUALITY OF LIFE AMONG
PATIENTS WITH CHRONIC LIVER DISEASE IN YUNNAN,
CHINA
Yanhua Che*, China
Vienna, Austria • April 22–26, 2015 339
P1274 DIAGNOSIS AND OUTCOMES AFTER 5YEARS OF FOLLOW-UP
P1275 Armando Peixoto*, Marco Silva, Pedro Pereira, Guilherme Macedo,
P1276 Portugal
P1277
P1278 SUPPORTIVE AND PALLIATIVE CARE IN ADVANCED LIVER
P1279 DISEASE: PATIENTS’ NEEDS AND PRIORITIES
P1280 Barbara M. Kimbell*, Marilyn Kendall, Kirsty Boyd, Scott A. Murray,
The United Kingdom
STIGMA AND DISCRIMINATION IN VIRAL HEPATITIS -
THE VOICE OF THE PATIENT
Carlos N. Varaldo*, Joana Costa, Ana R. Pascom, Vanuza M. Postigo,
Brazil
VITAMIN D SUPPLEMENTATION FOR CHRONIC LIVER
DISEASE - A COCHRANE HEPATO-BILIARY GROUP
SYSTEMATIC REVIEW
Goran Bjelakovic*, Dimitrinka Nikolova, Marija Bjelakovic,
Christian Gluud, Republic of Serbia
SCREENING FOR VIRAL HEPATITIS AMONG MIGRANTS
IN THE EU: WHAT LESSONS CAN WE LEARN FROM POOR
RESPONSE TO A PILOT TRIAL USING GP REGISTERS?
Jan Kunkel*, Lorna Sweeney, Abby Falla, Irene Veldhuijzen,
Graham R. Foster, The United Kingdom
EFFECTS OF “CHRONIC HEPATITIS PATIENTS
INFORMATION AND MORALE MEETINGS” ON PATIENT
COMPLIANCE AND TREATMENT SUCCESS
Orhan Sezgin*, Engin Altıntaş, Enver Üçbilek, Fehmi Ateş, Serkan Yaraş,
Bünyamin Sarıtaş, Mehmet K. Aydın, Turkey
MORTALITY, PREMATURE DEATH AND DIRECT COSTS
ASSOCIATED WITH LIVER DISEASE IN PORTUGAL
Sofia Vítor*, Rui T. Marinho, José Gíria, Portugal
THE DYNAMICS IN GENERAL AND LIVER DISEASE
SPECIFIC ASPECTS OF QUALITY OF LIFE AMONG
PATIENTS WITH CHRONIC LIVER DISEASE IN YUNNAN,
CHINA
Yanhua Che*, China
Vienna, Austria • April 22–26, 2015 339
